Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.19M Sell
19,859
-74
-0.4% -$25.3K 0.72% 38
2026
Q1
$7.01M Sell
19,933
-51
-0.3% -$18.2K 0.8% 27
2025
Q4
$6.54M Sell
19,984
-156
-0.8% -$49.5K 0.74% 31
2025
Q3
$5.68M Sell
20,140
-25
-0.1% -$7.25K 0.65% 37
2025
Q2
$5.63M Buy
20,165
+16
+0.1% +$4.53K 0.7% 35
2025
Q1
$6.28M Sell
20,149
-461
-2% -$136K 0.81% 29
2024
Q4
$5.37M Sell
20,610
-47
-0.2% -$13.9K 0.68% 40
2024
Q3
$6.66M Sell
20,657
-214
-1% -$70K 0.83% 31
2024
Q2
$6.52M Sell
20,871
-319
-2% -$93.7K 0.9% 25
2024
Q1
$6.02M Sell
21,190
-99
-0.5% -$29K 0.83% 30
2023
Q4
$6.13M Sell
21,289
-633
-3% -$172K 0.91% 22
2023
Q3
$5.89M Hold
21,922
0.92% 22
2023
Q2
$4.87M Sell
21,922
-490
-2% -$114K 0.73% 37
2023
Q1
$5.42M Sell
22,412
-100
-0.4% -$24.5K 0.84% 26
2022
Q4
$5.91M Buy
22,512
+334
+2% +$89.5K 0.9% 24
2022
Q3
$5M Buy
+22,178
New +$5.38M 0.81% 34

Other funds holding AMGN

Romano Brothers & Co's AMGN Position: Q2 2026 in Review

Romano Brothers & Co reduced its Amgen (AMGN) stake by 0.37% in Q2 2026, selling an estimated $25.3K and leaving 19,859 shares worth $7.19M. The position accounts for 0.72% of the portfolio, ranked #38.

Romano Brothers & Co first reported a position in AMGN in Q3 2022 and has held it in 16 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Romano Brothers & Co held 19,859 shares of Amgen worth $7.19M as of Q2 2026.
  • Romano Brothers & Co sold 74 Amgen shares in Q2 2026, an estimated $25.3K.
  • Amgen made up 0.72% of Romano Brothers & Co's portfolio in Q2 2026, its #38 holding.
  • Romano Brothers & Co first reported a position in Amgen in Q3 2022 and has held it in 16 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.